Shopping Cart
- Remove All
- Your shopping cart is currently empty
Trichosanatine and squamosamide, as potential candidates as lead compounds for further study in drug development process with the PP2A- α protein. Trichosanatine can alleviate oxidized low-density lipoprotein induced endothelial cells injury via inhibiting the LOX-1/p38 MAPK pathway.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $950 | Backorder | |
1 mL x 10 mM (in DMSO) | $970 | Backorder |
Description | Trichosanatine and squamosamide, as potential candidates as lead compounds for further study in drug development process with the PP2A- α protein. Trichosanatine can alleviate oxidized low-density lipoprotein induced endothelial cells injury via inhibiting the LOX-1/p38 MAPK pathway. |
Molecular Weight | 444.52 |
Formula | C27H28N2O4 |
Cas No. | 169626-16-8 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.